Table 4.
Distribution of symptoms by seropositivity among women and children at the baseline and follow-up surveys
| Baseline survey |
Follow-up survey |
|||
|---|---|---|---|---|
|
|
Symptomatic n (%)
|
Asymptomatic n (%)
|
Symptomatic n (%)
|
Asymptomatic n (%)
|
|
Women
|
|
|
|
|
| Seropositive |
94 (14.6%) |
545 (84.9%) |
206 (18.3%) |
909 (80.9%) |
| Seronegative |
153 (19.8%) |
615 (79.6%) |
47 (18.6%) |
205 (81.3%) |
|
Children
|
|
|
|
|
| Seropositive |
30 (17.8%) |
166 (81.8%) |
100 (16.4%) |
503 (82.3%) |
| Seronegative | 137 (15.3%) | 745 (83.3%) | 68 (15.0%) | 379 (83.8%) |